KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Entegris (ENTG) Research & Development (2016 - 2026)

Entegris has reported Research & Development over the past 17 years, most recently at $75.3 million for Q1 2026.

  • For Q1 2026, Research & Development fell 11.2% year-over-year to $75.3 million; the TTM value through Mar 2026 reached $319.5 million, down 2.92%, while the annual FY2025 figure was $329.0 million, 4.08% up from the prior year.
  • Research & Development for Q1 2026 was $75.3 million at Entegris, down from $79.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $84.8 million in Q1 2025 and troughed at $46.7 million in Q2 2022.
  • A 5-year average of $72.2 million and a median of $71.9 million in 2023 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: soared 54.84% in 2022 and later decreased 11.2% in 2026.
  • Year by year, Research & Development stood at $68.0 million in 2022, then dropped by 0.72% to $67.6 million in 2023, then increased by 20.64% to $81.5 million in 2024, then dropped by 3.07% to $79.0 million in 2025, then dropped by 4.68% to $75.3 million in 2026.
  • Business Quant data shows Research & Development for ENTG at $75.3 million in Q1 2026, $79.0 million in Q4 2025, and $80.9 million in Q3 2025.